Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Upgrade Now
Claim MarketBeat All Access Sale Promotion

John Wiley & Sons (WLYB) Financials

John Wiley & Sons logo
$41.21 0.00 (0.00%)
As of 05/21/2026
Annual Income Statements for John Wiley & Sons

Annual Income Statements for John Wiley & Sons

This table shows John Wiley & Sons' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/30/2015 4/30/2016 4/30/2017 4/30/2018 4/30/2019 4/30/2020 4/30/2021 4/30/2022 4/30/2023 4/30/2024 4/30/2025
Net Income / (Loss) Attributable to Common Shareholders
177 146 114 192 168 -74 148 148 17 -200 84
Consolidated Net Income / (Loss)
177 146 114 192 168 -74 148 148 17 -200 84
Net Income / (Loss) Continuing Operations
177 146 114 192 168 -74 148 148 17 -200 84
Total Pre-Tax Income
225 175 191 214 213 -63 176 210 33 -187 143
Total Operating Income
238 188 211 231 224 -54 186 219 56 52 221
Total Gross Profit
1,323 1,261 1,218 1,265 1,245 1,240 1,316 1,382 1,327 1,293 1,246
Total Revenue
1,822 1,727 1,719 1,796 1,800 1,831 1,942 2,083 2,020 1,873 1,678
Operating Revenue
1,822 1,727 1,719 1,796 1,800 1,831 1,942 2,083 2,020 1,873 1,678
Total Cost of Revenue
500 466 501 531 555 591 625 701 693 580 431
Operating Cost of Revenue
500 466 501 531 555 591 625 701 693 580 431
Total Operating Expenses
1,085 1,073 1,006 1,034 1,021 1,295 1,131 1,163 1,271 1,241 1,025
Selling, General & Admin Expense
1,005 994 943 953 964 997 1,023 1,080 1,037 1,014 947
Amortization Expense
51 50 50 48 55 62 75 85 85 56 52
Impairment Charge
- - - 3.60 0.00 202 0.00 0.00 100 108 0.00
Restructuring Charge
29 29 13 29 3.12 33 33 -1.43 49 63 26
Total Other Income / (Expense), net
-12 -13 -20 -18 -11 -8.81 -9.60 -9.62 -23 -239 -79
Interest Expense
17 17 17 13 16 25 18 20 38 49 53
Other Income / (Expense), net
1.74 0.47 -3.42 -4.26 5.08 16 8.78 10 15 -190 -26
Income Tax Expense
49 29 77 22 45 11 28 61 16 13 59
Basic Earnings per Share
$3.01 $2.51 $1.98 $3.37 $2.94 ($1.32) $2.65 $2.66 $0.31 ($3.65) $1.56
Weighted Average Basic Shares Outstanding
58.73M 58.00M 57.34M 57.04M 57.19M 56.21M 55.93M 55.76M 55.56M 54.95M 54.05M
Diluted Earnings per Share
$2.97 $2.48 $1.95 $3.32 $2.91 ($1.32) $2.63 $2.62 $0.31 ($3.65) $1.53
Weighted Average Diluted Shares Outstanding
59.59M 58.73M 58.20M 57.89M 57.84M 56.21M 56.46M 56.60M 56.36M 54.95M 54.83M
Weighted Average Basic & Diluted Shares Outstanding
58.80M 58.10M 57.40M 57M 57.20M 55.86M 55.85M 55.75M 55.28M 54.43M 53.39M

Quarterly Income Statements for John Wiley & Sons

This table shows John Wiley & Sons' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-92 -19 -114 25 -1.44 40 -23 68 12 45 30
Consolidated Net Income / (Loss)
-92 -19 -114 25 -1.44 40 -23 68 12 45 30
Net Income / (Loss) Continuing Operations
-92 -19 -114 25 -1.44 40 -23 68 12 45 30
Total Pre-Tax Income
-107 -22 -112 54 23 49 19 52 18 58 44
Total Operating Income
-16 46 -46 69 29 64 52 76 31 73 63
Total Gross Profit
294 337 317 345 295 320 300 332 288 317 302
Total Revenue
451 493 461 468 404 427 405 443 397 422 410
Operating Revenue
451 493 461 468 404 427 405 443 397 422 410
Total Cost of Revenue
157 156 144 123 109 107 104 111 109 104 108
Operating Cost of Revenue
157 156 144 123 109 107 104 111 109 104 108
Total Operating Expenses
310 291 363 276 266 255 249 255 257 244 240
Selling, General & Admin Expense
256 252 253 252 249 239 230 230 240 225 219
Amortization Expense
16 14 14 13 13 13 13 13 13 13 13
Impairment Charge
27 0.00 82 - - - - - - - 0.16
Restructuring Charge
12 25 15 11 3.87 3.63 5.57 12 3.04 6.03 7.06
Total Other Income / (Expense), net
-90 -68 -66 -15 -5.97 -15 -33 -24 -13 -15 -18
Interest Expense
11 13 13 11 13 14 14 11 11 12 11
Other Income / (Expense), net
-79 -55 -53 -3.37 6.82 -0.73 -19 -13 -2.21 -3.32 -6.71
Income Tax Expense
-14 -2.59 1.58 29 24 8.48 42 -16 6.01 13 15
Basic Earnings per Share
($1.67) ($0.35) ($2.08) $0.45 ($0.03) $0.75 ($0.43) $1.27 $0.22 $0.85 $0.57
Weighted Average Basic Shares Outstanding
55.27M 55.10M 54.81M 54.95M 54.38M 54.19M 53.95M 54.05M 53.38M 53.09M 52.25M
Diluted Earnings per Share
($1.67) ($0.35) ($2.08) $0.45 ($0.03) $0.74 ($0.43) $1.25 $0.22 $0.84 $0.56
Weighted Average Diluted Shares Outstanding
55.27M 55.10M 54.81M 54.95M 54.38M 54.85M 53.95M 54.83M 53.97M 53.52M 52.66M
Weighted Average Basic & Diluted Shares Outstanding
55.21M 54.87M 54.73M 54.43M 54.28M 54.03M 53.85M 53.39M 53.20M 52.56M 51.32M

Annual Cash Flow Statements for John Wiley & Sons

This table details how cash moves in and out of John Wiley & Sons' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/30/2015 4/30/2016 4/30/2017 4/30/2018 4/30/2019 4/30/2020 4/30/2021 4/30/2022 4/30/2023 4/30/2024 4/30/2025
Net Change in Cash & Equivalents
-29 -94 -305 108 -77 109 -109 6.37 6.54 -7.72 -14
Net Cash From Operating Activities
355 350 315 382 251 288 360 339 277 208 203
Net Cash From Continuing Operating Activities
355 350 315 382 251 288 360 339 277 208 203
Net Income / (Loss) Continuing Operations
177 146 114 192 168 -74 148 148 17 -200 84
Consolidated Net Income / (Loss)
177 146 114 192 168 -74 148 148 17 -200 84
Depreciation Expense
62 66 67 64 69 77 91 95 96 98 79
Amortization Expense
202 199 205 206 92 98 109 120 118 80 70
Non-Cash Adjustments To Reconcile Net Income
49 58 95 34 21 270 111 80 185 398 125
Changes in Operating Assets and Liabilities, net
-134 -119 -165 -114 -99 -83 -100 -104 -139 -169 -155
Net Cash From Investing Activities
-280 -151 -243 -177 -302 -347 -433 -194 -98 -107 -94
Net Cash From Continuing Investing Activities
-280 -151 -243 -177 -302 -347 -433 -194 -98 -107 -94
Purchase of Property, Plant & Equipment
-69 -86 -105 -114 -77 -89 -77 -89 -81 -76 -61
Acquisitions
-172 -20 -155 -27 -200 -231 -330 -82 8.29 -4.89 -11
Other Investing Activities, net
-38 -45 -44 -37 -24 -27 -26 -27 -26 -26 -21
Net Cash From Financing Activities
-61 -286 -346 -97 -18 173 -47 -132 -169 -107 -125
Net Cash From Continuing Financing Activities
-61 -286 -346 -97 -18 173 -47 -132 -169 -107 -125
Repayment of Debt
-718 -613 -923 -472 -482 -635 -544 -668 -1,054 -1,161 -1,182
Repurchase of Common Equity
-62 -70 -50 -40 -60 -47 -16 -30 -35 -45 -60
Payment of Dividends
-68 -70 -72 -74 -76 -77 -77 -77 -77 -77 -76
Issuance of Debt
759 467 683 459 596 934 593 651 1,005 1,185 1,200
Other Financing Activities, net
29 0.93 16 29 3.75 -3.79 -3.43 -7.11 -8.00 -8.50 -6.97
Other Net Changes in Cash
- - -31 - - -4.94 12 -7.07 -3.57 -1.49 3.15
Cash Interest Paid
15 15 16 12 15 24 17 18 36 47 51
Cash Income Taxes Paid
46 39 34 49 48 42 41 49 51 51 54

Quarterly Cash Flow Statements for John Wiley & Sons

This table details how cash moves in and out of John Wiley & Sons' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026
Net Change in Cash & Equivalents
-0.01 -7.64 9.29 -9.36 -10 -14 29 -19 -4.03 -14 28
Net Cash From Operating Activities
-82 -1.15 108 183 -89 -5.28 146 150 -85 8.50 180
Net Cash From Continuing Operating Activities
-82 -1.15 108 183 -89 -5.28 146 150 -85 8.50 180
Net Income / (Loss) Continuing Operations
-92 -19 -114 25 -1.44 40 -23 68 12 45 30
Consolidated Net Income / (Loss)
-92 -19 -114 25 -1.44 40 -23 68 12 45 30
Depreciation Expense
21 20 27 29 20 20 19 20 19 19 18
Amortization Expense
22 20 18 18 17 17 17 18 17 17 17
Non-Cash Adjustments To Reconcile Net Income
111 74 153 60 15 25 38 48 20 23 34
Changes in Operating Assets and Liabilities, net
-145 -96 24 50 -139 -107 95 -3.63 -154 -96 81
Net Cash From Investing Activities
-26 -26 -27 -28 -24 -21 -25 -24 99 -26 -27
Net Cash From Continuing Investing Activities
-26 -26 -27 -28 -24 -21 -25 -24 99 -26 -27
Purchase of Property, Plant & Equipment
-20 -20 -17 -19 -15 -15 -13 -19 -12 -13 -13
Acquisitions
-1.50 - -2.85 -10 -7.30 -1.73 -3.12 0.91 115 -1.04 -0.01
Other Investing Activities, net
-4.61 -6.51 -5.74 -0.40 -2.00 -4.42 -8.77 -6.11 -4.31 -12 -14
Net Cash From Financing Activities
106 24 -74 -163 102 11 -89 -149 -17 3.95 -127
Net Cash From Continuing Financing Activities
106 24 -74 -163 102 11 -89 -149 -17 3.95 -127
Repayment of Debt
-202 -182 -368 -409 -313 -312 -301 -256 -261 -175 -273
Repurchase of Common Equity
-10 -13 -6.50 -16 -13 -13 -10 -25 -14 -22 -35
Payment of Dividends
-19 -19 -19 -19 -19 -19 -19 -19 -19 -19 -19
Issuance of Debt
342 238 320 285 450 356 241 153 281 220 199
Other Financing Activities, net
-4.33 -0.28 -0.91 -2.99 -3.75 -0.22 -0.16 -2.84 -4.31 -0.02 -0.10
Other Net Changes in Cash
2.26 -4.20 2.38 -1.93 0.80 0.64 -3.06 4.76 -0.96 -0.48 1.73
Cash Interest Paid
11 12 13 11 12 14 14 11 11 11 11
Cash Income Taxes Paid
12 14 12 12 9.17 20 14 11 16 16 15

Annual Balance Sheets for John Wiley & Sons

This table presents John Wiley & Sons' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/30/2015 4/30/2016 4/30/2017 4/30/2018 4/30/2019 4/30/2020 4/30/2021 4/30/2022 4/30/2023 4/30/2024 4/30/2025
Total Assets
3,004 2,921 2,606 2,839 2,949 3,169 3,446 3,362 3,109 2,725 2,691
Total Current Assets
741 671 360 480 503 615 526 551 541 454 440
Cash & Equivalents
457 364 59 170 93 202 94 100 107 83 86
Accounts Receivable
147 168 189 212 307 309 312 332 310 224 228
Inventories, net
64 58 48 39 36 44 43 37 31 26 23
Prepaid Expenses
73 81 65 58 67 59 78 82 94 86 103
Plant, Property, & Equipment, net
193 215 243 290 289 298 282 272 247 192 162
Total Noncurrent Assets
2,070 2,036 2,003 2,070 2,157 2,256 2,638 2,539 2,320 2,079 2,089
Goodwill
962 952 982 1,020 1,096 1,117 1,304 1,302 1,204 1,091 1,122
Intangible Assets
918 877 828 848 866 807 1,015 931 855 616 595
Other Noncurrent Operating Assets
133 144 193 202 196 332 318 306 262 353 373
Total Liabilities & Shareholders' Equity
3,004 2,921 2,606 2,839 2,949 3,169 3,446 3,362 3,109 2,725 2,691
Total Liabilities
1,949 1,884 1,603 1,649 1,767 2,235 2,355 2,219 2,064 1,986 1,939
Total Current Liabilities
804 782 788 874 882 927 989 969 896 873 821
Short-Term Debt
100 - - - 0.00 9.38 13 19 5.00 7.50 10
Accounts Payable
161 166 76 90 91 94 96 77 84 56 61
Accrued Expenses
- - 63 73 78 87 79 102 113 97 110
Current Deferred Revenue
372 426 436 - - - - 538 - - 463
Current Employee Benefit Liabilities
99 103 104 116 97 108 145 117 80 97 93
Other Current Liabilities
62 76 86 581 595 615 657 116 612 578 84
Total Noncurrent Liabilities
1,146 1,102 815 775 885 1,308 1,366 1,250 1,312 1,112 1,118
Long-Term Debt
650 605 365 360 479 766 809 768 743 767 789
Noncurrent Deferred & Payable Income Tax Liabilities
199 190 160 144 144 119 173 180 288 97 105
Noncurrent Employee Benefit Liabilities
210 224 215 190 166 188 146 79 86 71 72
Other Noncurrent Operating Liabilities
87 83 75 81 96 235 238 223 195 166 152
Commitments & Contingencies
- - - - - - - - 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,055 1,037 1,003 1,191 1,181 850 1,091 1,142 1,045 740 752
Total Preferred & Common Equity
1,055 1,037 1,003 1,191 1,181 934 1,091 1,142 1,045 740 752
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,055 1,037 1,003 1,191 1,181 850 1,091 1,139 1,045 740 752
Common Stock
436 452 471 490 505 432 528 542 553 558 565
Retained Earnings
1,597 1,673 1,715 1,834 1,931 1,780 1,850 1,921 1,861 1,583 1,591
Accumulated Other Comprehensive Income / (Loss)
-407 -448 -507 -440 -509 -575 -491 -512 -529 -528 -479
Other Equity Adjustments
- - - - - - - - - -873 -925

Quarterly Balance Sheets for John Wiley & Sons

This table presents John Wiley & Sons' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 10/31/2022 1/31/2023 7/31/2023 10/31/2023 1/31/2024 7/31/2024 10/31/2024 1/31/2025 7/31/2025 10/31/2025 1/31/2026
Total Assets
3,128 3,150 2,926 2,779 2,707 2,652 2,609 2,600 2,524 2,467 2,561
Total Current Assets
483 531 478 426 384 393 370 395 420 381 411
Cash & Equivalents
118 126 75 83 93 83 76 105 82 67 95
Accounts Receivable
260 284 153 147 161 192 183 185 220 210 200
Inventories, net
34 33 30 30 28 26 27 25 22 21 19
Prepaid Expenses
70 88 80 59 69 87 85 80 96 83 97
Plant, Property, & Equipment, net
250 248 224 223 208 185 172 165 152 147 142
Total Noncurrent Assets
2,395 2,371 2,225 2,131 2,115 2,074 2,066 2,041 1,952 1,939 2,008
Goodwill
1,268 1,203 1,102 1,082 1,097 1,100 1,102 1,079 1,118 1,116 1,139
Intangible Assets
861 868 657 631 629 609 598 572 580 582 595
Other Noncurrent Operating Assets
267 299 224 216 370 365 366 389 253 241 275
Total Liabilities & Shareholders' Equity
3,128 3,150 2,926 2,779 2,707 2,652 2,609 2,600 2,524 2,467 2,561
Total Liabilities
2,051 2,123 1,989 1,912 1,959 1,938 1,854 1,915 1,791 1,727 1,811
Total Current Liabilities
635 761 706 610 712 689 561 717 649 540 692
Short-Term Debt
44 5.00 5.00 5.00 6.25 8.75 10 10 10 10 11
Accounts Payable
46 32 44 49 45 39 40 53 36 48 50
Accrued Expenses
102 154 99 106 151 105 119 156 113 126 177
Current Deferred Revenue
- 369 370 236 301 367 241 313 362 219 293
Current Employee Benefit Liabilities
84 81 52 83 78 49 61 74 45 53 70
Other Current Liabilities
358 119 86 90 97 96 90 110 84 85 91
Total Noncurrent Liabilities
1,416 1,362 1,283 1,302 1,247 1,250 1,292 1,197 1,142 1,186 1,119
Long-Term Debt
979 941 891 938 901 910 951 877 818 862 796
Noncurrent Deferred & Payable Income Tax Liabilities
157 145 110 94 95 97 99 95 104 103 107
Noncurrent Employee Benefit Liabilities
76 78 81 76 72 68 71 70 72 72 73
Other Noncurrent Operating Liabilities
205 199 185 180 169 169 171 156 148 149 143
Commitments & Contingencies
- - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,078 1,027 937 867 748 714 755 685 733 740 750
Total Preferred & Common Equity
1,078 1,027 937 867 748 714 755 685 733 740 750
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,078 1,027 937 867 748 714 755 685 733 740 750
Common Stock
548 553 548 554 557 556 562 566 563 568 573
Retained Earnings
1,903 1,812 1,749 1,710 1,577 1,563 1,584 1,542 1,584 1,610 1,621
Accumulated Other Comprehensive Income / (Loss)
-546 -506 -517 -542 -527 -524 -496 -519 -478 -481 -453
Other Equity Adjustments
- - - - - - - - - -957 -991

Annual Metrics And Ratios for John Wiley & Sons

This table displays calculated financial ratios and metrics derived from John Wiley & Sons' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/30/2015 4/30/2016 4/30/2017 4/30/2018 4/30/2019 4/30/2020 4/30/2021 4/30/2022 4/30/2023 4/30/2024 4/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
2.66% -5.23% -0.49% 4.51% 0.22% 1.75% 6.01% 7.28% -3.03% -7.27% -10.43%
EBITDA Growth
8.25% -9.92% 5.67% 3.87% -21.61% -64.89% 187.96% 12.71% -36.11% -86.29% 755.76%
EBIT Growth
14.34% -21.25% 10.32% 9.20% 0.82% -116.65% 609.52% 18.10% -69.13% -294.85% 241.57%
NOPAT Growth
9.93% -15.88% -19.85% 65.36% -14.88% -121.47% 511.43% -0.79% -81.24% 25.72% 256.50%
Net Income Growth
10.19% -17.58% -22.05% 69.11% -12.45% -144.15% 299.57% 0.04% -88.38% -1,262.42% 142.01%
EPS Growth
10.00% -16.50% -21.37% 70.26% -12.35% -145.36% 299.24% -0.38% -88.17% -1,277.42% 141.92%
Operating Cash Flow Growth
1.98% -1.45% -10.02% 21.41% -34.39% 14.99% 24.78% -5.79% -18.29% -25.06% -2.43%
Free Cash Flow Firm Growth
132.69% -3.62% -58.27% 44.84% -106.93% 343.28% -778.86% 192.81% 117.10% -17.94% -40.44%
Invested Capital Growth
-3.46% -5.15% 2.45% 5.43% 13.50% -3.90% 20.77% 0.54% -15.66% -14.41% 2.76%
Revenue Q/Q Growth
-0.84% -0.42% 1.05% 1.41% 0.78% -0.90% 3.28% 0.45% -0.96% -2.99% -1.52%
EBITDA Q/Q Growth
2.02% -1.68% 4.88% 2.93% -23.10% -63.93% 389.00% 0.42% 14.86% -46.06% -3.30%
EBIT Q/Q Growth
2.95% -6.15% 11.26% 7.87% 4.27% -117.84% 950.27% 0.93% 124.84% -28.67% -0.95%
NOPAT Q/Q Growth
6.91% -7.49% 14.77% -0.02% 5.63% -124.01% 712.59% 3.90% 30.52% -20.76% 113.51%
Net Income Q/Q Growth
6.64% -8.01% 12.31% 4.00% 5.77% -150.54% 390.03% 1.24% 316.36% -27.40% 103.62%
EPS Q/Q Growth
6.83% -7.81% 12.72% 4.08% 5.82% -151.36% 392.22% 1.16% 282.35% -27.62% 109.59%
Operating Cash Flow Q/Q Growth
1.88% 10.19% -31.91% 38.31% 2.88% 0.30% 1.57% -6.73% 18.24% -16.18% -13.99%
Free Cash Flow Firm Q/Q Growth
103.31% -4.78% -40.86% 1.69% 84.29% 200.96% -92.31% -6.12% 203.27% -23.59% -37.92%
Invested Capital Q/Q Growth
-10.92% -11.53% -6.11% -5.96% -7.60% -19.77% -5.90% -5.13% -16.44% -15.01% -0.15%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
72.58% 73.01% 70.86% 70.43% 69.18% 67.73% 67.79% 66.36% 65.71% 69.05% 74.29%
EBITDA Margin
27.63% 26.26% 27.89% 27.72% 21.68% 7.48% 20.32% 21.35% 14.07% 2.08% 20.48%
Operating Margin
13.05% 10.89% 12.31% 12.89% 12.44% -2.96% 9.56% 10.53% 2.77% 2.79% 13.20%
EBIT Margin
13.14% 10.92% 12.11% 12.65% 12.73% -2.08% 10.01% 11.02% 3.51% -7.37% 11.65%
Profit (Net Income) Margin
9.71% 8.44% 6.61% 10.70% 9.35% -4.06% 7.64% 7.12% 0.85% -10.70% 5.02%
Tax Burden Percent
78.45% 83.40% 59.46% 89.84% 79.01% 117.74% 84.28% 70.74% 52.06% 107.10% 58.90%
Interest Burden Percent
94.15% 92.69% 91.86% 94.16% 92.96% 165.45% 90.54% 91.37% 46.72% 135.50% 73.11%
Effective Tax Rate
21.55% 16.60% 40.54% 10.16% 20.99% 0.00% 15.72% 29.26% 47.94% 0.00% 41.10%
Return on Invested Capital (ROIC)
13.60% 11.95% 9.72% 15.46% 12.01% -2.47% 9.40% 8.50% 1.73% 2.56% 9.02%
ROIC Less NNEP Spread (ROIC-NNEP)
9.79% 7.79% 5.30% 9.12% 8.98% -9.44% 8.23% 7.54% -0.28% -41.39% 2.41%
Return on Net Nonoperating Assets (RNNOA)
2.22% 1.99% 1.42% 2.06% 2.18% -4.84% 5.87% 4.78% -0.15% -25.00% 2.26%
Return on Equity (ROE)
15.81% 13.94% 11.14% 17.52% 14.19% -7.31% 15.27% 13.28% 1.58% -22.45% 11.28%
Cash Return on Invested Capital (CROIC)
17.11% 17.23% 7.30% 10.17% -0.64% 1.50% -9.42% 7.97% 18.71% 18.08% 6.29%
Operating Return on Assets (OROA)
7.88% 6.37% 7.53% 8.34% 7.92% -1.25% 5.87% 6.74% 2.19% -4.73% 7.22%
Return on Assets (ROA)
5.82% 4.92% 4.11% 7.06% 5.81% -2.43% 4.48% 4.36% 0.53% -6.87% 3.11%
Return on Common Equity (ROCE)
15.81% 13.94% 11.14% 17.52% 14.19% -7.31% 15.27% 13.26% 1.57% -22.45% 11.28%
Return on Equity Simple (ROE_SIMPLE)
16.76% 14.06% 11.33% 16.14% 14.24% -7.96% 13.59% 12.98% 1.65% -27.08% 11.19%
Net Operating Profit after Tax (NOPAT)
186 157 126 208 177 -38 156 155 29 37 130
NOPAT Margin
10.23% 9.08% 7.32% 11.58% 9.83% -2.07% 8.05% 7.45% 1.44% 1.95% 7.77%
Net Nonoperating Expense Percent (NNEP)
3.80% 4.16% 4.42% 6.34% 3.03% 6.97% 1.17% 0.96% 2.00% 43.95% 6.61%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 8.41%
Cost of Revenue to Revenue
27.42% 26.99% 29.14% 29.57% 30.82% 32.27% 32.21% 33.64% 34.29% 30.95% 25.71%
SG&A Expenses to Revenue
55.15% 57.58% 54.89% 53.07% 53.53% 54.46% 52.67% 51.83% 51.36% 54.11% 56.48%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
59.54% 62.11% 58.55% 57.55% 56.74% 70.69% 58.24% 55.83% 62.95% 66.26% 61.09%
Earnings before Interest and Taxes (EBIT)
239 189 208 227 229 -38 194 229 71 -138 195
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
503 454 479 498 390 137 394 445 284 39 344
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.41 2.15 2.40 2.59 1.89 2.15 2.62 2.29 1.95 2.76 3.12
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.39 1.29 1.40 1.72 1.24 1.00 1.47 1.25 1.01 1.09 1.40
Price to Earnings (P/E)
14.35 15.30 21.21 16.07 13.24 0.00 19.28 17.61 118.30 0.00 27.92
Dividend Yield
2.68% 3.11% 3.66% 2.38% 4.24% 4.17% 2.68% 2.94% 3.78% 3.76% 3.23%
Earnings Yield
6.97% 6.54% 4.71% 6.22% 7.55% 0.00% 5.19% 5.68% 0.85% 0.00% 3.58%
Enterprise Value to Invested Capital (EV/IC)
2.10 1.93 2.07 2.37 1.67 1.60 1.97 1.80 1.74 2.07 2.09
Enterprise Value to Revenue (EV/Rev)
1.55 1.43 1.58 1.83 1.45 1.31 1.85 1.58 1.33 1.46 1.83
Enterprise Value to EBITDA (EV/EBITDA)
5.62 5.45 5.67 6.59 6.70 17.54 9.09 7.42 9.43 70.14 8.92
Enterprise Value to EBIT (EV/EBIT)
11.82 13.11 13.06 14.43 11.41 0.00 18.46 14.37 37.83 0.00 15.68
Enterprise Value to NOPAT (EV/NOPAT)
15.18 15.75 21.61 15.77 14.77 0.00 22.94 21.26 92.11 74.67 23.49
Enterprise Value to Operating Cash Flow (EV/OCF)
7.97 7.06 8.63 8.57 10.42 8.33 9.96 9.73 9.67 13.16 15.12
Enterprise Value to Free Cash Flow (EV/FCFF)
12.06 10.92 28.77 23.97 0.00 104.18 0.00 22.70 8.50 10.55 33.66
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.71 0.58 0.36 0.30 0.41 0.91 0.75 0.69 0.72 1.05 1.06
Long-Term Debt to Equity
0.62 0.58 0.36 0.30 0.41 0.90 0.74 0.67 0.71 1.04 1.05
Financial Leverage
0.23 0.26 0.27 0.23 0.24 0.51 0.71 0.63 0.54 0.60 0.94
Leverage Ratio
2.72 2.83 2.71 2.48 2.44 3.01 3.41 3.05 2.96 3.27 3.63
Compound Leverage Factor
2.56 2.63 2.49 2.34 2.27 4.98 3.08 2.79 1.38 4.43 2.65
Debt to Total Capital
41.55% 36.84% 26.68% 23.22% 28.84% 47.68% 42.95% 40.79% 41.73% 51.15% 51.52%
Short-Term Debt to Total Capital
5.54% 0.00% 0.00% 0.00% 0.00% 0.58% 0.65% 0.97% 0.28% 0.50% 0.64%
Long-Term Debt to Total Capital
36.01% 36.84% 26.68% 23.22% 28.84% 47.10% 42.30% 39.82% 41.45% 50.66% 50.88%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
58.45% 63.16% 73.32% 76.78% 71.16% 52.32% 57.05% 59.02% 58.27% 48.85% 48.48%
Debt to EBITDA
1.49 1.33 0.76 0.72 1.23 5.66 2.08 1.77 2.63 19.89 2.33
Net Debt to EBITDA
0.58 0.53 0.64 0.38 0.99 4.18 1.84 1.54 2.26 17.75 2.08
Long-Term Debt to EBITDA
1.29 1.33 0.76 0.72 1.23 5.59 2.05 1.73 2.62 19.70 2.30
Debt to NOPAT
4.02 3.86 2.90 1.73 2.71 -20.39 5.25 5.07 25.72 21.17 6.13
Net Debt to NOPAT
1.57 1.54 2.44 0.91 2.18 -15.07 4.66 4.43 22.05 18.90 5.47
Long-Term Debt to NOPAT
3.49 3.86 2.90 1.73 2.71 -20.15 5.18 4.95 25.54 20.97 6.05
Altman Z-Score
2.37 2.27 2.55 2.76 2.39 1.70 2.07 2.20 2.02 1.77 2.25
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.16% 0.17% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.92 0.86 0.46 0.55 0.57 0.66 0.53 0.57 0.60 0.52 0.54
Quick Ratio
0.75 0.68 0.31 0.44 0.45 0.55 0.41 0.45 0.47 0.35 0.38
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
235 226 94 137 -9.48 23 -157 145 315 259 91
Operating Cash Flow to CapEx
513.77% 405.05% 299.74% 334.71% 325.05% 325.57% 464.97% 396.76% 422.56% 272.92% 329.56%
Free Cash Flow to Firm to Interest Expense
13.75 13.54 5.58 10.30 -0.59 0.92 -8.52 7.34 8.36 5.28 1.73
Operating Cash Flow to Interest Expense
20.80 20.95 18.59 28.80 15.56 11.56 19.58 17.12 7.34 4.24 3.86
Operating Cash Flow Less CapEx to Interest Expense
16.75 15.78 12.39 20.20 10.77 8.01 15.37 12.81 5.60 2.68 2.69
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.60 0.58 0.62 0.66 0.62 0.60 0.59 0.61 0.62 0.64 0.62
Accounts Receivable Turnover
12.28 10.97 9.65 8.96 6.94 5.95 6.25 6.47 6.29 7.01 7.41
Inventory Turnover
7.18 7.67 9.48 12.16 14.78 14.93 14.52 17.71 20.58 20.36 17.57
Fixed Asset Turnover
9.55 8.47 7.51 6.74 6.22 6.24 6.69 7.52 7.79 8.52 9.46
Accounts Payable Turnover
3.29 2.85 4.13 6.38 6.13 6.40 6.60 8.09 8.56 8.28 7.40
Days Sales Outstanding (DSO)
29.73 33.27 37.84 40.75 52.62 61.38 58.37 56.38 58.01 52.06 49.24
Days Inventory Outstanding (DIO)
50.87 47.59 38.49 30.02 24.70 24.45 25.14 20.61 17.74 17.93 20.77
Days Payable Outstanding (DPO)
111.03 128.28 88.39 57.20 59.57 57.02 55.30 45.12 42.63 44.07 49.33
Cash Conversion Cycle (CCC)
-30.43 -47.43 -12.06 13.57 17.74 28.81 28.21 31.87 33.12 25.92 20.68
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,348 1,278 1,310 1,381 1,567 1,506 1,819 1,829 1,543 1,320 1,466
Invested Capital Turnover
1.33 1.32 1.33 1.34 1.22 1.19 1.17 1.14 1.20 1.31 1.16
Increase / (Decrease) in Invested Capital
-48 -69 31 71 186 -61 313 9.82 -286 -222 39
Enterprise Value (EV)
2,831 2,472 2,717 3,278 2,614 2,403 3,586 3,298 2,680 2,732 3,064
Market Capitalization
2,538 2,230 2,411 3,088 2,228 1,830 2,858 2,611 2,039 2,040 2,350
Book Value per Share
$17.97 $17.97 $17.49 $20.74 $20.66 $15.17 $19.53 $20.44 $18.85 $13.51 $13.97
Tangible Book Value per Share
($14.05) ($13.71) ($14.08) ($11.80) ($13.64) ($19.15) ($21.99) ($19.65) ($18.28) ($17.67) ($17.91)
Total Capital
1,805 1,642 1,368 1,551 1,660 1,625 1,913 1,929 1,793 1,514 1,552
Total Debt
750 605 365 360 479 775 822 787 748 775 799
Total Long-Term Debt
650 605 365 360 479 766 809 768 743 767 789
Net Debt
293 241 306 190 386 573 728 687 642 691 714
Capital Expenditures (CapEx)
69 86 105 114 77 89 77 85 66 76 61
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-420 -475 -487 -564 -473 -505 -544 -500 -456 -495 -457
Debt-free Net Working Capital (DFNWC)
37 -111 -428 -394 -380 -303 -450 -400 -349 -412 -371
Net Working Capital (NWC)
-63 -111 -428 -394 -380 -312 -463 -419 -354 -419 -381
Net Nonoperating Expense (NNE)
9.63 11 12 16 8.72 36 8.09 6.80 12 237 46
Net Nonoperating Obligations (NNO)
293 241 306 190 386 656 728 687 498 581 714
Total Depreciation and Amortization (D&A)
264 265 271 271 161 175 200 215 213 177 148
Debt-free, Cash-free Net Working Capital to Revenue
-23.06% -27.50% -28.32% -31.41% -26.26% -27.60% -28.02% -24.01% -22.57% -26.43% -27.23%
Debt-free Net Working Capital to Revenue
2.04% -6.43% -24.91% -21.96% -21.10% -16.54% -23.19% -19.19% -17.29% -21.98% -22.11%
Net Working Capital to Revenue
-3.44% -6.43% -24.91% -21.96% -21.10% -17.05% -23.83% -20.09% -17.54% -22.38% -22.71%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.01 $2.51 $1.98 $3.37 $2.94 ($1.32) $2.65 $2.66 $0.31 ($3.65) $1.56
Adjusted Weighted Average Basic Shares Outstanding
58.73M 58.00M 57.34M 57.04M 57.19M 56.21M 55.93M 55.76M 55.56M 54.95M 54.05M
Adjusted Diluted Earnings per Share
$2.97 $2.48 $1.95 $3.32 $2.91 ($1.32) $2.63 $2.62 $0.31 ($3.65) $1.53
Adjusted Weighted Average Diluted Shares Outstanding
59.59M 58.73M 58.20M 57.89M 57.84M 56.21M 56.46M 56.60M 56.36M 54.95M 54.83M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $2.94 ($1.32) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
58.86M 57.58M 57.20M 57.50M 56.63M 55.86M 55.85M 55.75M 55.28M 54.43M 53.39M
Normalized Net Operating Profit after Tax (NOPAT)
209 181 134 237 179 126 184 154 107 157 145
Normalized NOPAT Margin
11.47% 10.47% 7.78% 13.19% 9.97% 6.91% 9.50% 7.40% 5.29% 8.36% 8.67%
Pre Tax Income Margin
12.37% 10.12% 11.12% 11.91% 11.83% -3.44% 9.06% 10.07% 1.64% -9.99% 8.52%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
14.02 11.29 12.28 17.12 14.21 -1.53 10.57 11.59 1.88 -2.82 3.72
NOPAT to Interest Expense
10.92 9.39 7.42 15.66 10.98 -1.52 8.50 7.83 0.77 0.75 2.48
EBIT Less CapEx to Interest Expense
9.98 6.12 6.08 8.51 9.42 -5.08 6.36 7.27 0.14 -4.37 2.55
NOPAT Less CapEx to Interest Expense
6.87 4.22 1.22 7.06 6.19 -5.07 4.29 3.52 -0.97 -0.81 1.31
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
38.73% 47.95% 62.96% 38.27% 45.02% -103.19% 51.90% 52.06% 448.55% -38.42% 90.42%
Augmented Payout Ratio
73.77% 95.95% 107.24% 58.92% 80.67% -165.91% 62.53% 72.28% 651.65% -60.91% 162.22%

Quarterly Metrics And Ratios for John Wiley & Sons

This table displays calculated financial ratios and metrics derived from John Wiley & Sons' official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026
DEI Shares Outstanding
- - - - - - - - - - 52,558,394.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 52,558,394.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.56
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
-11 32 -32 32 -1.81 53 -64 100 20 56 42
Return On Investment Capital (ROIC_SIMPLE)
- - -1.96% - - - -4.05% 6.42% 1.31% 3.50% 2.69%
Earnings before Interest and Taxes (EBIT)
-95 -9.09 -99 65 36 63 33 64 29 70 56
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-52 31 -54 113 73 100 69 101 65 106 92
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
463 541 260 254 -134 -115 22 60 115 153 47
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,443 1,473 1,553 1,320 1,574 1,641 1,468 1,466 1,479 1,544 1,462
Increase / (Decrease) in Invested Capital
-474 -509 -293 -222 132 168 -86 39 -95 -96 -5.54
Book Value per Share
$16.95 $15.71 $13.64 $13.51 $13.11 $13.91 $12.68 $13.97 $13.73 $13.91 $14.27
Tangible Book Value per Share
($14.88) ($15.30) ($17.81) ($17.67) ($18.29) ($17.42) ($17.88) ($17.91) ($18.08) ($18.01) ($18.72)
Total Capital
1,833 1,810 1,655 1,514 1,632 1,716 1,572 1,552 1,561 1,612 1,558
Total Debt
896 943 907 775 919 961 887 799 828 872 808
Total Long-Term Debt
891 938 901 767 910 951 877 789 818 862 796
Net Debt
821 859 814 691 836 885 783 714 746 804 712
Capital Expenditures (CapEx)
20 20 17 19 15 15 13 19 12 13 13
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-298 -263 -415 -495 -370 -257 -417 -457 -300 -217 -365
Debt-free Net Working Capital (DFNWC)
-223 -180 -322 -412 -287 -181 -312 -371 -219 -149 -270
Net Working Capital (NWC)
-228 -185 -328 -419 -296 -191 -322 -381 -229 -159 -281
Net Nonoperating Expense (NNE)
81 52 81 6.91 -0.37 13 -41 32 8.76 12 12
Net Nonoperating Obligations (NNO)
505 606 805 581 861 885 783 714 746 804 712
Total Depreciation and Amortization (D&A)
44 40 45 48 37 37 36 38 36 36 36
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1.67) ($0.35) ($2.08) $0.45 ($0.03) $0.75 ($0.43) $1.27 $0.22 $0.85 $0.57
Adjusted Weighted Average Basic Shares Outstanding
55.27M 55.10M 54.81M 54.95M 54.38M 54.19M 53.95M 54.05M 53.38M 53.09M 52.25M
Adjusted Diluted Earnings per Share
($1.67) ($0.35) ($2.08) $0.45 ($0.03) $0.74 ($0.43) $1.25 $0.22 $0.84 $0.56
Adjusted Weighted Average Diluted Shares Outstanding
55.27M 55.10M 54.81M 54.95M 54.38M 54.85M 53.95M 54.83M 53.97M 53.52M 52.66M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
55.21M 54.87M 54.73M 54.43M 54.28M 54.03M 53.85M 53.39M 53.20M 52.56M 51.32M
Normalized Net Operating Profit after Tax (NOPAT)
16 50 35 56 23 56 40 62 22 61 47
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Financials Breakdown Chart

Key Financial Trends

Here is a concise, data-driven snapshot of JOHN WILEY & SONS, INC. (NYSE: WLYB) performance across the last four years, focusing on the most relevant quarterly cash flow, income statement, and balance sheet data. The bullets highlight notable trends that may matter to retail investors.

  • Net income and earnings per share improved in Q2 2026 relative to a year earlier: Net income rose to $44.9 million in Q2 2026 from $40.5 million in Q2 2025, and diluted earnings per share increased to $0.84 from $0.22. Positive momentum in profitability.
  • Gross margin showed meaningful improvement in Q2 2026: gross profit was $317.4 million on $421.8 million of revenue (about 75% gross margin), versus $287.5 million gross profit on $426.6 million revenue in Q2 2025 (about 67.5% margin). Healthy margin expansion.
  • Quarterly EPS per share metrics remain favorable despite revenue variability: basic EPS was $0.85 and diluted EPS $0.84 in Q2 2026, versus roughly $0.22 in Q2 2025, signaling improved profitability on a per-share basis. Per-share profitability improving.
  • Financing activity provided liquidity support in Q2 2026: debt issuance of $219.8 million and net debt repayments of $175.5 million contributed to a small net cash inflow from financing activities of about $3.95 million. Access to debt markets and modest financing cash flow.
  • Revenue in Q2 2026 was $421.8 million, slightly down versus Q2 2025 at $426.6 million, reflecting typical quarterly/seasonal swings rather than a clear year-over-year growth trend. Revenue fluctuates seasonally.
  • Balance sheet scale remains solid: Total assets stand at about $2.47 billion with total liabilities around $1.73 billion and total equity near $0.74 billion in Q2 2026. Reasonable leverage and a stable capital base.
  • The company holds a sizable long-term debt load at about $0.86 billion, which is typical for a capital-intensive publisher but warrants watching for debt refinement as cash flow evolves. Leverage risk to monitor.
  • Cash on hand was $67.4 million at the end of Q2 2026, down from higher levels earlier in 2026, indicating modest liquidity compression. Liquidity to monitor.
  • Quarterly cash flow mix shows pressure on overall cash from operations and investing: net cash from continuing operating activities was a modest outflow (reported as a debit of $8.5 million in Q2 2026), net investing cash outflows were $26.4 million, and the quarter ended with a net decrease in cash of $14.4 million. Cash burn pressure in the period.
  • Accumulated other comprehensive income (loss) is negative by about $481 million, contributing to a lower overall equity position and indicating potential headwinds from non-operating items. OCI headwind to consider for long-term equity value.
05/23/26 07:51 AM ETAI Generated. May Contain Errors.

John Wiley & Sons Financials - Frequently Asked Questions

According to the most recent income statement we have on file, John Wiley & Sons' financial year ends in April. Their financial year 2025 ended on April 30, 2025.

John Wiley & Sons' net income appears to be on a downward trend, with a most recent value of $84.16 million in 2025, falling from $176.87 million in 2015. The previous period was -$200.32 million in 2024. View John Wiley & Sons' forecast to see where analysts expect John Wiley & Sons to go next.

John Wiley & Sons' total operating income in 2025 was $221.41 million, based on the following breakdown:
  • Total Gross Profit: $1.25 billion
  • Total Operating Expenses: $1.02 billion

Over the last 10 years, John Wiley & Sons' total revenue changed from $1.82 billion in 2015 to $1.68 billion in 2025, a change of -7.9%.

John Wiley & Sons' total liabilities were at $1.94 billion at the end of 2025, a 2.3% decrease from 2024, and a 0.5% decrease since 2015.

In the past 10 years, John Wiley & Sons' cash and equivalents has ranged from $58.52 million in 2017 to $457.44 million in 2015, and is currently $85.88 million as of their latest financial filing in 2025.

Over the last 10 years, John Wiley & Sons' book value per share changed from 17.97 in 2015 to 13.97 in 2025, a change of -22.3%.



Financial statements for NYSE:WLYB last updated on 3/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners